Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 17, 2007 - Issue 4
Submit an article Journal homepage
32
Views
6
CrossRef citations to date
0
Altmetric
Patent Evaluation

A H3 antagonist for treating allergic rhinitis: a development candidate?

Glaxo Group Ltd: WO2006090142

Dr Peter Norman Norman Consulting, 18 Pink Lane, Burnham, Buckinghamshire, SL1 8JW, UK. [email protected]
Pages 449-452 | Published online: 19 Apr 2007

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Peter Norman. (2011) New H1/H3 antagonists for treating allergic rhinitis: WO2010094643. Expert Opinion on Therapeutic Patents 21:3, pages 425-429.
Read now
Graham Beaton & Wilna J Moree. (2010) The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005 – 2010. Expert Opinion on Therapeutic Patents 20:9, pages 1197-1218.
Read now
Michael Berlin & Christopher W Boyce. (2007) Recent advances in the development of histamine H3 antagonists. Expert Opinion on Therapeutic Patents 17:6, pages 675-687.
Read now

Articles from other publishers (3)

Nakisa Ghamari, Omid Zarei, José-Antonio Arias-Montaño, David Reiner, Siavoush Dastmalchi, Holger Stark & Maryam Hamzeh-Mivehroud. (2019) Histamine H3 receptor antagonists/inverse agonists: Where do they go?. Pharmacology & Therapeutics 200, pages 69-84.
Crossref
Sylvain Celanire, Florence Lebon & Holger Stark. 2008. The Third Histamine Receptor. The Third Histamine Receptor 103 165 .
Kerstin Sander, Tim Kottke & Holger Stark. (2008) Histamine H3 Receptor Antagonists Go to Clinics. Biological and Pharmaceutical Bulletin 31:12, pages 2163-2181.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.